期刊文献+

抑制骨吸收药物的现状及进展 被引量:15

原文传递
导出
摘要 现代社会骨质疏松患者越多越多,用于骨质疏松症预防和治疗的药物种类很多。本文综述了抑制骨吸收药物的作用机制、研究现状及进展,并对该类药物的应用前景作了展望。
出处 《国外医学(老年医学分册)》 2003年第2期91-94,共4页 Foreign Medical Sciences(Geriatrics)
  • 相关文献

参考文献13

  • 1White JP,Schilling JS. Postmenopausal hormone replacement: historical perspectives and current concerns.Clin Excell Nurse Pract,2000;4(5):277~285
  • 2This P, Cormier C. Approach of menopause in women at risk for breast cancer.Gynecol Obstet Fertil,2002;30(2):101~113
  • 3Lufkin EG, Wong M, Deal C. The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis.Rheum Dis Clin North Am,2001;27(1):163~185
  • 4Licata AA, Ciaccia AV, Wong M et al. Raloxifene: a new choice for treating and preventing osteoporosis.Cleve Clin J Med,2000;64(4):273~280
  • 5Katase K, Kato T, Hirai Y et al. Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause: a randomized placebo-controlled study. Calcif Tissue Int,2001;69(2):73~77
  • 6Alexandersen P, Toussaint A, Christiansen C et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.JAMA,2001;285(11):1482~1488
  • 7Araki H, Futagami K, Gomita Y. The development of new drugs for osteoporosis in Japan.Nippon Yakurigaku Zallhi,2001;117(5):359~366
  • 8Chapurlat RD, Delmas PD. Risedronate: clinical usage.Int J Clin Pract,2001;55(4):275~278
  • 9Roux C, Dougados M. Calcitonin in glucocorticoid-induced osteoporsis.Front Horm Res,2002;30:145~149
  • 10Hodsman AB,Fracher LJ,Watson PH et al. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone vesus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal woman with osteoporosis.J Clin Endocrinol Metab,1997;82(2):620~628

同被引文献225

引证文献15

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部